(Q54377755)

29 May 2018

title

High risk human papillomavirus genotyping in clinical samples: evaluation of different commercial tests. (English)

1 reference

29 May 2018

1 reference

2

1 reference

29 May 2018

Maria Benevolo

4

1 reference

29 May 2018

author name string

F Paolini

1

1 reference

29 May 2018

R Brandi

3

1 reference

29 May 2018

L Mariani

5

1 reference

29 May 2018

M C Cercato

6

1 reference

29 May 2018

A Vocaturo

7

1 reference

29 May 2018

A Venuti

8

1 reference

29 May 2018

publication date

1 January 2011

1 reference

29 May 2018

International Journal of Immunopathology and Pharmacology

published in

1 reference

29 May 2018

volume

24

1 reference

29 May 2018

issue

1

1 reference

29 May 2018

page(s)

127-138

1 reference

29 May 2018

Papillomaviruses and cancer: from basic studies to clinical application

cites work

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

Classification of papillomaviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

Epidemiologic classification of human papillomavirus types associated with cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

High-risk HPV testing in women with borderline and mild dyskaryosis: long-term follow-up data and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2–3

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

Processing of long-stored archival cervical smears for human papillomavirus detection by the polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 assay in detection of high-risk human papillomavirus and diagnosis of biopsy-confirmed high-grade cervical disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

Comparison of the Digene HC2 assay and the Roche AMPLICOR human papillomavirus (HPV) test for detection of high-risk HPV genotypes in cervical samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

Projected Clinical Benefits and Cost-effectiveness of a Human Papillomavirus 16/18 Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

Comparison of the performance of different HPV genotyping methods for detecting genital HPV types.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

Prevalence and determinants of genital infection with papillomavirus, in female and male university students in Busan, South Korea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

High prevalence of genital human papillomavirus type 52 and 58 infection in women attending gynecologic practitioners in South Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

High-risk HPV types in lesions of the uterine cervix of female commercial sex workers in the Philippines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

Analytical evaluation of the PapilloCheck test, a new commercial DNA chip for detection and genotyping of human papillomavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F039463201102400115

10.1177/039463201102400115

21 January 2018

Identifiers

DOI

1 reference

29 May 2018

PubMed ID

21496395

1 reference

29 May 2018